Cue Biopharma Is A Clinical Stage Biopharmaceutical Company Based In Bostonmassachusettsthe Company Focuses On Developing Innovative Therapies For Cancer And Autoimmune Diseases By Modulating The Human Immune Systemutilizing Its Proprietary Immuno Stat Platformcue Biopharma Engineers Therapeutic Biologics That Selectively Engage And Modulate Targeted T Cellsaiming To Enhance The Body S Intrinsic Immune Response The Company Is Actively Involved In Clinical Trials And Research Servicestranslating Natural Signals Into Protein Therapeuticsits Product Pipeline Includes Cue 101Cue 102And Cue 103Which Target Various Disease Indicationsincluding Immune Oncology And Autoimmune Disorderscue Biopharma Has Established Partnerships With Major Pharmaceutical Companiesincluding Boehringer Ingelheimto Advance Its Research And Development Efforts
